Skip to main content
. 2020 Sep 6;184(1):50–59. doi: 10.1111/bjd.19341

Figure 1.

Figure 1

Study design. The hatched area from week 52 to week 64 corresponds to two additional doses administered to patients in France. The additional doses did not affect efficacy assessments performed at week 52.